As businesses continue their digital transformation journeys, they are exposed to an ever-expanding attack surface. With the proliferation of cloud environments, remote work, and the increasing use of ...

StreamHub has been named the winner of the DVB-I user interface competition, taking the top prize of €10,000 for its Android ...

Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia ...

Akeso, Inc. (9926.HK) announced that its supplemental New Drug Application (sNDA) for gumokimab (AK111), a novel humanized anti-IL-17A monoclonal antibody for the treatment of active ankylosing ...

ESET MDR delivers industry-leading real-time detection and a mean-time-to-respond (MTTR) of 6 minutes to keep businesses ...

Khalil Gibran's enduring wisdom highlights how suffering can forge strong souls and resilient characters, transforming pain ...

The Chinese regulator has accepted the New Drug Application for Illuccix, Telix’s lead imaging agent for prostate cancer. The ...

From last hop to intelligent edgeFast, predictable networks become an enabler of how teams want to work and how spaces need ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the Chinese National Medical Products ...

HONG KONG SAR - Media OutReach Newswire - 19 January 2026 - Jamf, (NASDAQ: JAMF), the standard in managing and securing Apple ...

For on-site diagnostics, SpeakerMATE includes onboard red and green LEDs to indicate communication status, along with an ...

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU ® (trastuzumab deruxtecan) in combination with pertuzumab for the first-line ...